{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:45:06Z","timestamp":1769607906163,"version":"3.49.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Irish Research Council"},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.bioorg.2018.12.003","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T02:35:45Z","timestamp":1543890945000},"page":"418-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["N-Alkyl-1,5-dideoxy-1,5-imino-l-fucitols as fucosidase inhibitors: Synthesis, molecular modelling and activity against cancer cell lines"],"prefix":"10.1016","volume":"84","author":[{"given":"Jian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind","family":"Negi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Styliana I.","family":"Mirallai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Warta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christel","family":"Herold-Mende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Carty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1529-6540","authenticated-orcid":false,"given":"Xin-Shan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul V.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2018.12.003_b0005","doi-asserted-by":"crossref","first-page":"7321","DOI":"10.1021\/ja00044a068","article-title":"Specificity, inhibition, and synthetic utility of a recombinant human alpha-1,3-fucosyl-transferase","volume":"114","author":"Wong","year":"1992","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2018.12.003_b0010","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/1568026033452474","article-title":"Design, synthesis and biological evaluation of iminosugar-based glycosyltransferase inhibitors","volume":"3","author":"Compain","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0015","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2174\/1381612033454919","article-title":"Glucose analog inhibitors of glycogen phosphorylases as potential antidiabetic agents: recent developments","volume":"9","author":"Somsak","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2018.12.003_b0020","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2174\/1568026033452465","article-title":"Imino-sugar-based nucleosides","volume":"3","author":"Schramm","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0025","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.1016\/S0040-4039(99)01844-4","article-title":"An approach to combinatorial library generation of galactofuranose mimics as potential inhibitors of mycobacterial cell wall biosynthesis: Synthesis of a peptidomimetic of uridine 5 '-diphosphogalactofuranose (UDP-Galf)","volume":"40","author":"Lee","year":"1999","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2018.12.003_b0030","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1016\/S0040-4039(97)01539-6","article-title":"Inhibition of UDP-Gal mutase and mycobacterial galactan biosynthesis by pyrrolidine analogues of galactofuranose","volume":"38","author":"Lee","year":"1997","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2018.12.003_b0035","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1021\/jm0304313","article-title":"Azasugar-based MMP\/ADAM inhibitors as antipsoriatic agents","volume":"47","author":"Moriyama","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0040","series-title":"Iminosugars as Glycosidase Inhibitors: Nojirimycin and Beyond","author":"St\u00fctz","year":"1999"},{"key":"10.1016\/j.bioorg.2018.12.003_b0045","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/(SICI)1521-3773(19990816)38:16<2300::AID-ANIE2300>3.0.CO;2-6","article-title":"Carbohydrate mimetics: a new strategy for tackling the problem of carbohydrate-mediated biological recognition","volume":"38","author":"Sears","year":"1999","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2018.12.003_b0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1039\/B915870G","article-title":"Glycosidase inhibition: assessing mimicry of the transition state","volume":"8","author":"Gloster","year":"2010","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1021\/cr000433k","article-title":"Recent developments of transition-state analogue glycosidase inhibitors of non-natural product origin","volume":"102","author":"Lillelund","year":"2002","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2018.12.003_b0060","article-title":"Iminosugars: Recent insights into their bioactivity and potential as therapeutic agents \u2013 preface","volume":"3","author":"Martin","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0065","doi-asserted-by":"crossref","first-page":"41r","DOI":"10.1093\/glycob\/cwg054","article-title":"Fucose: biosynthesis and biological function in mammals","volume":"13","author":"Becker","year":"2003","journal-title":"Glycobiology"},{"key":"10.1016\/j.bioorg.2018.12.003_b0070","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4052\/tigg.8.391","article-title":"alpha 1,3-fucosyltransferases","volume":"8","author":"Staudacher","year":"1996","journal-title":"Trends Glycosci. Glycotechnol."},{"key":"10.1016\/j.bioorg.2018.12.003_b0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrd1751","article-title":"Glycans in cancer and inflammation. Potential for therapeutics and diagnostics","volume":"4","author":"Dube","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2018.12.003_b0080","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000012188","article-title":"Value of the serum alpha-L-fucosidase activity in the diagnosis of colorectal cancer","volume":"59","author":"Ayude","year":"2000","journal-title":"Oncology"},{"key":"10.1016\/j.bioorg.2018.12.003_b0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12253-008-9036-x","article-title":"Cell surface associated alpha-L-fucose moieties modulate human breast cancer neoplastic progression","volume":"14","author":"Yuan","year":"2008","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.bioorg.2018.12.003_b0090","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0300-9084(01)01323-2","article-title":"Activity of fucosyltransferases and altered glycosylation in cystic fibrosis airway epithelial cells","volume":"83","author":"Glick","year":"2001","journal-title":"Biochimie"},{"key":"10.1016\/j.bioorg.2018.12.003_b0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1155\/2008\/206510","article-title":"Carbohydrate markers in colon carcinoma","volume":"25","author":"Szajda","year":"2008","journal-title":"Dis. Markers"},{"key":"10.1016\/j.bioorg.2018.12.003_b0100","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1039\/c3cs60056d","article-title":"Development of fucosyltransferase and fucosidase inhibitors","volume":"42","author":"Tu","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2018.12.003_b0105","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.bmcl.2005.11.100","article-title":"Asymmetric synthesis of the l-fuco-nojirimycin, a nanomolar \u03b1-l-fucosidase inhibitor","volume":"16","author":"Dubernet","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.12.003_b0110","first-page":"35","article-title":"Novel \u03b1-L-fucosidase inhibitors from the bark of Angylocalyx pynaertii (Leguminosae)","volume":"268","author":"Asano","year":"2001","journal-title":"FEBS J."},{"key":"10.1016\/j.bioorg.2018.12.003_b0115","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1016\/j.bmcl.2010.09.065","article-title":"N-(8-(3-ethynylphenoxy) octyl-1-deoxynojirimycin suppresses growth and migration of human lung cancer cells","volume":"20","author":"Zhao","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.12.003_b0120","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1747-0285.2010.00968.x","article-title":"Biological study of the angiogenesis inhibitor N-(8-(3-ethynylphenoxy) octyl-1-deoxynojirimycin","volume":"75","author":"Zhao","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2018.12.003_b0125","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1016\/j.bmc.2008.05.012","article-title":"Hybrids of 1-deoxynojirimycin and aryl-1, 2, 3-triazoles and biological studies related to angiogenesis","volume":"16","author":"Zhao","year":"2008","journal-title":"Bioorgan. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0130","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/(SICI)1096-9136(199808)15:8<657::AID-DIA652>3.0.CO;2-7","article-title":"Long-term effectiveness of a new \u03b1-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated Type 2 diabetes mellitus","volume":"15","author":"Mitrakou","year":"1998","journal-title":"Diabet. Med."},{"key":"10.1016\/j.bioorg.2018.12.003_b0135","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1016\/j.bmc.2006.08.003","article-title":"\u03b1-1-C-Octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease","volume":"14","author":"Yu","year":"2006","journal-title":"Bioorgan. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0140","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1016\/j.bmcl.2004.09.086","article-title":"\u03b1-1-C-Alkyl-1-deoxynojirimycin derivatives as potent and selective inhibitors of intestinal isomaltase: remarkable effect of the alkyl chain length on glycosidase inhibitory profile","volume":"14","author":"Godin","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.12.003_b0145","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1021\/jm801506m","article-title":"Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease","volume":"52","author":"Wang","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0150","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cbpa.2007.05.035","article-title":"Gaucher disease","volume":"11","author":"Butters","year":"2007","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bioorg.2018.12.003_b0155","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/mt.2009.53","article-title":"The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts","volume":"17","author":"Porto","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bioorg.2018.12.003_b0160","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1021\/jm060677i","article-title":"Isofagomine-and 2, 5-anhydro-2, 5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention","volume":"50","author":"Yu","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0165","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1021\/jo061280p","article-title":"Development of adamantan-1-yl-methoxy-functionalized 1-deoxynojirimycin derivatives as selective inhibitors of glucosylceramide metabolism in man","volume":"72","author":"Wennekes","year":"2007","journal-title":"J. Organ. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0170","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1021\/bi052559n","article-title":"Discovery of different types of inhibition between the human and Thermotoga maritima \u03b1-Fucosidases by fuconojirimycin-based derivatives","volume":"45","author":"Ho","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2018.12.003_b0175","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0960-894X(97)00189-3","article-title":"Synthesis of inhibitors of \u03b1-1, 3-fucosyltransferase","volume":"7","author":"Jefferies","year":"1997","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.12.003_b0180","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0014-5793(88)80185-6","article-title":"Inhibition of HIV replication by amino-sugar derivatives","volume":"237","author":"Fleet","year":"1988","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2018.12.003_b0185","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/(SICI)1522-2675(19990707)82:7<1044::AID-HLCA1044>3.0.CO;2-3","article-title":"Synthesis of an L-fucose-derived cyclic nitrone and its conversion to \u03b1-L-fucosidase Inhibitors","volume":"82","author":"Peer","year":"1999","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.bioorg.2018.12.003_b0190","first-page":"953","article-title":"Monosaccharide mit stickstoff im ring, XXXIX. Synthese von modifizierten \u03b1-L-fucosidase-inhibitoren, die 1,5-didesoxy-1,5-imino-L-fucit als Basisstruktur enthalten","author":"Paulsen","year":"1990","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0195","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1246\/cl.1988.969","article-title":"Synthesis of 2-acetoxy-4-formylphenyl 2,3-Di-O-acetyl-6-deoxy-beta-D-arabino-5-hexulofuranoside, structure confirmation of the anomeric configuration of antibiotic hygromycin-A","author":"Chida","year":"1988","journal-title":"Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.12.003_b0200","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1021\/jo00009a009","article-title":"Total synthesis of antibiotic hygromycin-A","volume":"56","author":"Chida","year":"1991","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0205","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1039\/C39850000841","article-title":"Synthesis from D-Glucose of 1,5-Dideoxy-1,5-Imino-L-Fucitol, a Potent Alpha-L-Fucosidase Inhibitor","author":"Fleet","year":"1985","journal-title":"J. Chem. Soc. Chem. Commun."},{"key":"10.1016\/j.bioorg.2018.12.003_b0210","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1021\/jo00090a040","article-title":"Expeditious Synthesis of Azasugars by the Double Reductive Amination of Dicarbonyl Sugars","volume":"59","author":"Baxter","year":"1994","journal-title":"J Org Chem"},{"key":"10.1016\/j.bioorg.2018.12.003_b0215","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1021\/jo960057x","article-title":"Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures","volume":"61","author":"AbdelMagid","year":"1996","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0220","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1021\/ol048619j","article-title":"Cp*Ir complex-catalyzed N-heterocyclization of primary amines with diols: a new catalytic system for environmentally benign synthesis of cyclic amines","volume":"6","author":"Fujita","year":"2004","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2018.12.003_b0225","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1016\/S0957-4166(00)00209-3","article-title":"Asymmetric reduction of enantiopure imines with zinc borohydride: stereoselective synthesis of chiral amines","volume":"11","author":"Cimarelli","year":"2000","journal-title":"Tetrahedron-Asymmetry"},{"key":"10.1016\/j.bioorg.2018.12.003_b0230","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1021\/jm060677i","article-title":"Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention","volume":"50","author":"Yu","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0235","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.bmc.2007.11.036","article-title":"An expeditious one-pot synthesis of 1,6-dideoxy-N-alkylated nojirimycin derivatives and their inhibitory effects on the secretion of IFN-gamma and IL-4","volume":"16","author":"Zhou","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0240","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1002\/anie.200604932","article-title":"Inhibition of lipid A stimulated activation of human dendritic cells and macrophages by amino and hydroxylamino monosaccharides","volume":"46","author":"Peri","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2018.12.003_b0245","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1021\/jo9820115","article-title":"Glycosidase inhibitors: synthesis of enantiomerically pure aza-sugars from Schiff base amino esters via tandem reduction-alkenylation and osmylation","volume":"64","author":"Polt","year":"1999","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0250","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1016\/S0040-4039(00)76704-9","article-title":"A simple asymmetric-synthesis of 2-substituted 2,3-dihydro-4-pyridones","volume":"35","author":"Streith","year":"1994","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2018.12.003_b0255","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/hlca.19950780106","article-title":"Chelate-controlled asymmetric-synthesis of 2-substituted 2,3-dihydropyridin-4(1h)-ones \u2013 synthesis of D-aminodeoxyaltrose and L-aminodeoxyaltrose derivatives","volume":"78","author":"Streith","year":"1995","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.bioorg.2018.12.003_b0260","doi-asserted-by":"crossref","first-page":"13119","DOI":"10.1074\/jbc.M313783200","article-title":"Crystal structure of Thermotoga maritima alpha-L-fucosidase \u2013 insights into the catalytic mechanism and the molecular basis for fucosidosis","volume":"279","author":"Sulzenbacher","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0265","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1016\/S0960-894X(02)00627-3","article-title":"Convenient synthesis and evaluation of enzyme inhibitory activity of several N-alkyl-, N-phenylalkyl, and cyclic isourea derivatives of 5a-Carba-alpha-DL-fucopyranosylamine","volume":"12","author":"Ogawa","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.12.003_b0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings1","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2018.12.003_b0275","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.1016\/j.bmcl.2013.08.029","article-title":"Setting expectations in molecular optimizations: strengths and limitations of commonly used composite parameters","volume":"23","author":"Shultz","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.12.003_b0280","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/anie.200905597","article-title":"Structural basis of \u03b1-fucosidase inhibition by iminocyclitols with Ki values in the micro-to picomolar range","volume":"49","author":"Wu","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2018.12.003_b0285","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bioorg.2017.09.017","article-title":"Coumarinyl pyranopyrimidines as new neuropeptide S receptor antagonists; design, synthesis, homology and molecular docking","volume":"75","author":"Batran","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0290","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4155\/fmc.13.207","article-title":"Reverse docking: a powerful tool for drug repositioning and drug rescue","volume":"6","author":"Kharkar","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0295","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s00204-015-1587-5","article-title":"Toxicophore exploration as a screening technology for drug design and discovery: techniques, scope and limitations","volume":"90","author":"Singh","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bioorg.2018.12.003_b0300","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jsps.2018.01.017","article-title":"Inverse docking based screening and identification of protein targets for Cassiarin alkaloids against Plasmodium falciparum","volume":"26","author":"Negi","year":"2018","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.bioorg.2018.12.003_b0305","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejmech.2018.11.030","article-title":"Ligand design for somatostatin receptor isoforms 4 and 5","volume":"163","author":"Negi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0310","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/path.4366","article-title":"Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma","volume":"234","author":"Campos","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.bioorg.2018.12.003_b0315","doi-asserted-by":"crossref","first-page":"12899","DOI":"10.1039\/c0cp00151a","article-title":"Scoring functions and their evaluation methods for protein\u2013ligand docking: recent advances and future directions","volume":"12","author":"Huang","year":"2010","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.bioorg.2018.12.003_b0320","first-page":"949","article-title":"Wild-type and mutated IDH1\/2 enzymes and therapy responses","volume":"37","author":"Molenaar","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2018.12.003_b0325","unstructured":"Chemical Computing Group ULC, Molecular Operating Environment (MOE), 2018.01, 2018."},{"key":"10.1016\/j.bioorg.2018.12.003_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/520435","article-title":"Cystathionine \u03b2-lyase-like protein with pyridoxal binding domain characterized in Leishmania major by comparative sequence analysis and homology modelling","volume":"2013","author":"Negi","year":"2013","journal-title":"ISRN Comput. Biol."},{"key":"10.1016\/j.bioorg.2018.12.003_b0335","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.bioorg.2018.12.003_b0340","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.bioorg.2018.12.003_b0345","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-2836(63)80023-6","article-title":"Stereochemistry of polypeptide chain configurations","volume":"7","author":"Ramachandran","year":"1963","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2018.12.003_b0350","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.bioorg.2018.12.003_b0355","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/356083a0","article-title":"Assessment of protein models with three-dimensional profiles","volume":"356","author":"L\u00fcthy","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2018.12.003_b0360","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1021\/acs.orglett.5b00404","article-title":"Decorated macrocycles via ring-closing double-reductive amination. Identification of an apoptosis inducer of leukemic cells that at least partially antagonizes a 5-HT2 receptor","volume":"17","author":"Zhou","year":"2015","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2018.12.003_b0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2014.11.004","article-title":"Design, microwave-mediated synthesis and biological evaluation of novel 4-aryl (alkyl) amino-3-nitroquinoline and 2,4-diaryl (dialkyl) amino-3-nitroquinolines as anticancer agents","volume":"58","author":"Chauhan","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2018.12.003_b0370","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ijc.11188","article-title":"Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck","volume":"106","author":"Ninck","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2018.12.003_b0375","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/ijc.22867","article-title":"Combination of thalidomide and cisplatin in an head and neck squamous cell carcinomas model results in an enhanced antiangiogenic activity in vitro and in vivo","volume":"121","author":"Vasvari","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2018.12.003_b0380","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1158\/1078-0432.CCR-16-3217","article-title":"Identification of a novel ITG\u03b1v\u03b26-binding peptide using protein separation and phage display","volume":"23","author":"Altmann","year":"2017","journal-title":"Clin. Cancer Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818311519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818311519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T06:44:32Z","timestamp":1565246672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818311519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":76,"alternative-id":["S0045206818311519"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.12.003","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-Alkyl-1,5-dideoxy-1,5-imino-l-fucitols as fucosidase inhibitors: Synthesis, molecular modelling and activity against cancer cell lines","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}